Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen

No Thumbnail Available

Date

2011-02

Journal Title

Journal ISSN

Volume Title

Publisher

Clinical Infectious Diseases

Abstract

Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P >.05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment. © The Author 2011.

Description

Keywords

Citation